Hydrosome Labs Announces Promising Microbiome Results From Pre-Clinical Trial of Ultrafine Bubbles

Study Reveals Significant Potential of Innovative Water Technology in Enhancing Gut Health and Reducing Inflammation

Chicago, Illinois, October 29, 2024 – Hydrosome Labs, a Chicago-based biotechnology company, today announced results from a pre-clinical trial on Hydrosome H2O—its unique technology that leverages ultrafine bubbles to enhance the delivery of active ingredients to cells.

The study demonstrates the potential for regular consumption of Hydrosome H2O to positively impact gut health by increasing microbiome diversity and reducing inflammatory markers in mammals. About 30 years ago, scientists began to investigate the formation of very tiny bubbles in water, sometimes called ultrafine bubbles. These bubbles, invisible to the naked eye and among the smallest ever detected, have unique properties. Hydrosome Labs’ ultrafine bubbles, “Hydrosomes,” possess characteristics no other water technology has:

• A significantly higher surface area than bubbles in regular water (1 trillion fit in one champagne bubble) makes them excellent transporters to cells.
• Products leveraging “Hydrosomes” have a longer shelf life (up to 18 months or more) than any other ultrafine bubble technology. The closest shelf life in the emerging category is four to six months.
• The process is sustainable. The patented process does not add chemicals or consumables and requires little energy.

Commercial uses include improving nutrient uptake in skincare, driving more efficient and sustainable processes for precision fermentation, delivering faster, longer-lasting, enhanced hydration in performance drinks, and helping plants grow faster and healthier with less fertilizer.

The Microbiome study builds upon previous peer-reviewed research highlighting the link between ultrafine bubble water and gut microbiome diversity. The trial was conducted on mammalian test subjects and compared populations consuming purified water with and without ultrafine bubbles. The trial went beyond existing research by looking at longer-term consumption (12 weeks vs. 4-8 weeks for previous research) and critical health measures.

Results indicated statistically significant changes in gut microbiome composition consistent with prior studies. Most notably, significant increases in short-chain fatty acids, including butyrate, iso-valerate, and valerate, were observed, alongside decreases in inflammatory markers such as IL-1BETA, TNF-ALPHA, and IL-10. Commercial applications could ultimately include various products in the food and beverage categories.

The microbiome’s diversity influences gut health and is pivotal to digestion, nutrient absorption, and immune function. A well-balanced microbiome supports overall health, while dysbiosis, or an imbalance in the microbiome, can lead to various health issues.

“These results open new avenues for advancing our research into human applications and exploring different gases within the bubbles to benefit the microbiome further,” said Bob Jacobs, President of Hydrosome Labs.

Hydrosome Labs is now seeking partners to transition this promising research into human trials and expand its scope to explore additional effects of ultrafine bubbles on the gut microbiome. This includes expanding the scope of pre-clinical efforts to include the impact of different gases inside the bubbles (e.g., N2, H2) on the gut microbiome.

Hydrosome Labs is releasing the new research at Supply Side West, a leading industry conference for the food and beverage, pet health, and personal care industries.

For more information, please visit www.hydrosomelabs.com.

ABOUT HYDROSOME LABS

Hydrosome Labs is a Chicago-based B-to-B biotechnology company on a mission to change lives by changing water. Its technology, Hydrosome H2O, is a natural and chemical-free process that improves the power of water through the emerging science of ultrafine bubbles. The innovative process delivers active ingredients to cells more efficiently and completely with multiple applications across precision fermentation, personal care and cosmetics, beverages, and controlled environment agriculture. The company and advisors include business and R&D executives from Fortune 500 companies like P&G, Constellation Brands, Goldman Sachs, Nestle Health Sciences, and the Intercontinental Exchange, owner of the New York Stock Exchange. For more information, visit www.hydrosomelabs.com.

###

Media Contact:

Amber Long 513.313.4045 amber@teahousecommunications.com